Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Fluidigm Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 07:00PM GMT
Release Date Price: $5.57 (+5.69%)
Matthew Stanton
Jefferies LLC - Analyst

Good afternoon. Welcome to the Day 2 of the Jefferies Global Healthcare Conference. My name is Matt Stanton. I'm a member of the tools and diagnostics team here at Jefferies. It's my pleasure to have Fluidigm with us here at the conference again this year.

Joining us from the team we have President and CEO, Chris Linthwaite, as well as CFO, Vikram Jog. Gentlemen, thanks for joining us today.

Chris Linthwaite
Fluidigm Corp. - President and CEO

Hi, Matt, thank you for including us and just thrilled to be here at Jefferies Healthcare conference. I appreciate the opportunity to present.

Vikram Jog
Fluidigm Corp. - CFO

Yes, great to be here.

Questions & Answers

Matthew Stanton
Jefferies LLC - Analyst

So, I guess, Chris, to kick it off, there's been a lot of debate (inaudible) within the analytical and tools space, focused on areas like multi-omics, proteomics, spatial-omics, seen a number of recent IPOs and SPACs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot